(Q34929239)

5 August 2017

title

Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models (English)

1 reference

5 August 2017

0 references

1 reference

Haihao Sun

1

1 reference

5 August 2017

Stephen Pisle

series ordinal

2

1 reference

5 August 2017

Erin R Gardner

series ordinal

3

1 reference

5 August 2017

William D Figg

series ordinal

4

1 reference

5 August 2017

publication date

9 July 2010

1 reference

Cancer Biology and Therapy

5 August 2017

published in

1 reference

5 August 2017

volume

10

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

38-43

1 reference

Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

The role of focal-adhesion kinase in cancer - a new therapeutic opportunity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

A potential role for imaging technology in anticancer efficacy evaluations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

FAK regulates biological processes important for the pathogenesis of cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

Use of reporter genes for optical measurements of neoplastic disease in vivo

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

Angiogenesis and tumor metastasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087944

Bioluminescent indicators in living mammals

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.1.11993

Imaging transgene expression in live animals

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.1.11993

Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.1.11993

In vivo imaging of NF-kappa B activity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20495381

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/CBT.10.1.11993

1 reference

5 August 2017

1 reference

5 August 2017

1 reference